The significance of airway responsiveness in the onset and evolution of chronic obstructive pulmonary disease

Clinical and Experimental Allergy

Volumn 27, Issue 10, 1997, Pages 1114-1119

  De Jong, J W ^a   Koeter G H ^a   Postma, D S ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; REVIEW;

ANTIGENS, CD19; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; FORCED EXPIRATORY VOLUME; HUMANS; LUNG DISEASES, OBSTRUCTIVE; METHACHOLINE CHLORIDE; PREDICTIVE VALUE OF TESTS; SMOKING; T-LYMPHOCYTES;

EID: 0030880829     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1997.tb01147.x     Document Type: Review

References (49)

1. Bradley BL, Azzawi M, Jacobson M et al. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991; 88:661-74.
2. Kerstjens HAM, Brand PLP, Hughes MD et al. and the Dutch chronic non-specific lung disease study group. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med 1992; 327:1413-9.
3. Juniper EF, Kline PA, Vanzieleghem A et al. Effect of long-term treatment with an inhaled corticosterid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 1990; 142:832-6.
4. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991; 325:388-92.
5. Postma DS, Renkema TEJ, Noordhoek JA et al. Association between nonspecific bronchial hyperreactivity and superoxide anion production by polymorphonuclear leukocytes in chronic air-flow obstruction. Am Rev Respir Dis 1988; 137:57-61.
6. Bosken CH, Hards J, Gatter K, Hogg JC. Characterization of the inflammatory reaction in the peripheral airways of cigarette smokers using immunocytochemistry. Am Rev Respir Dis 1992; 145:911-7.
7. Saetta M, Di Stefano A, Maestrelli P et al. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 1993; 147:301-6.
8. Pesci A, Rossi GA, Bertorelli G et al. Mast cells in the airway lumen and bronchial mucosa of patients with chronic bronchitis. Am J Respir Crit Care Med 1994; 149:1311-6.
9. 1. Am J Respir Crit Care Med 1995; 151:1377-82.
10. O'Connor GT, Sparrow D, Weiss ST. A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary-function decline: the normative aging study. Am J Respir Crit Care Med 1995; 152:87-92.
11. 1 in male smokers and ex-smokers. Thorax 1985; 40:9-16.
12. Tabona M, Chan-Yeung M, Enarson D et al. Host factors affecting longitudinal decline in lung spirometry among grain elevator workers. Chest 1984; 85:182-6.
13. 1 decline. Preliminary results in a working population. Bull Eur Physiopathol Respir 1987; 23:397-400.
14. 1. A longitudinal study in the elderly. Am J Respir Crit Care Med 1995; 151:656-62.
15. Campbell AH, Barter CE, O'Connell JM, Huggins R. Factors affecting the decline of ventilatory function in chronic bronchitis. Thorax 1985; 40:741-8.
16. Barter CE, Campbell AH. Relationship of constitutional factors and cigarette smoking to decrease in 1-second forced expiratory volume. Am Rev Respir Dis 1976; 113:305-14.
17. Postma DS, de Vries K, Koëter GH, Sluiter HJ. Independent influence of reversibility of airflow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction. Am Rev Respir Dis 1986; 134:276-80.
18. Finkelstein R, Ma HD, Ghezzo H et al. Morphometry of small airways in smokers and its relationship to emphysema type and hyperresponsiveness. Am J Respir Crit Care Med 1995; 152:267-76.
19. de Jong JW, van der Belt-Gritter B, Kauffman HF, Postma DS. In vivo and in vitro effects of nedocromil sodium on polymorphonuclear leukocytes in patients with COPD. Eur Resp J 1994; 7:120s, P0593.
20. Oosterhoff Y, de Jong JW, Jansen MAM, Koëter GH, Postma DS. Airway responsiveness to adenosine 5′-monophosphate in chronic obstructive pulmonary disease is determined by smoking. Am Rev Respir Dis 1993; 147:553-8.
21. Sterk PJ, Bel EH. In vivo challenge. The shape of the doseresponse curve to inhaled bronchoconstrictor agents in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 143:1433-7.
22. Oosterhoff Y, Postma DS, Koëter GH. Inflammation and airways hyperresponsiveness in asthma. Res Clin Forums 1992; 14:65-74.
23. Tashkin DP, Altose MD, Connett JE et al. and the Lung Health Study Research Group. Airway hyperresponsiveness in irreversible chronic obstructive pulmonary disease, in Provocation testing in clinical practice (Spector SL ed), New York, USA: Marcel Dekker, Inc., 1995:575-98.
24. Tashkin DP, Altose MD, Connett JE et al. for the Lung Health Study Research Group. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153:1802-11.
25. Dantzker D.R. (Chairman) et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-44.
26. Postma DS, de Graaf-Breederveld N, Koëter GH, Sluiter HJ. The relationship between reversibility and hyperreactivity. Eur Respir J 1988; 5:483-5.
27. Wiggs BR, Bosken C, Paré PD, James A, Hogg JC. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 145:1251-8.
28. Bosken CH, Wiggs BR, Paré PD, Hogg JC. Small airway dimensions in smokers with obstruction to airflow. Am Rev Respir Dis 1990; 142:563-70.
29. Linden M, Rasmussen JB, Piitulainen E et al. Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis. Am Rev Respir Dis 1993; 148:1226-32.
30. Thompson AB, Daughton D, Robbins RA et al. Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am Rev Respir Dis 1989; 140:1527-37.
31. de Jong JW, van der Belt-Gritter B, Koëter GH, Postma DS. Peripheral blood lymphocyte cell subsets in subjects with chronic obstructive pulmonary disease: Association with smoking, IgE and lung function. Resp Med 1997; 91:67-76.
32. O'Connor GT, Sparrow D, Weiss ST. The role of allergy and nonspecific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease. State of the art. Am Rev Respir Dis 1989; 140:225-52.
33. Rijcken B, Schouten JP, Weiss ST, Speizer FE, Van der Lende R. The relationship between airway responsiveness to histamine and pulmonary function level in a random population sample. Am Rev Respir Dis 1988; 137:826-32.
34. Peat JK, Woolcock AJ, Cullen K. Decline of lung function and development of chronic airflow limitation: a longitudinal study of non-smokers and smokers in Busselton, Western Australia. Thorax 1990; 45:32-7.
35. Burrows B, Knudson RJ, Camilli AE, Lyle SK, Lebowitz MD. The horse-racing effect and predicting decline in forced expiratory volume in one second from screening spirometry. Am Rev Respir Dis 1987; 135:788-93.
36. Britt EB, Cohen B, Menkes H et al. Airways reactivity and functional deterioration in relatives of COPD patients. Chest 1980; 77:260-1.
37. Peat JK, Salome CM, Sedgwick CS, Kerrebijn J, Woolcock AJ. A prospective study of bronchial responsiveness and respiratory symptoms in a population of Australian schoolchildren. Clin Exp Allergy 1989; 19:299-306.
38. Bascom R, Bromberg PhA, Costa DA et al. Health effects of outdoor air pollution (part 1). State of the art. Am J Respir Crit Care Med 1996; 153:3-50.
39. Bascom R, Bromberg PhA, Costa DA et al. Health effects of outdoor air pollution (part 2). State of the art. Am J Respir Crit Care Med 1996; 153:477-98.
40. Fletcher Ch, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1:1645-8.
41. Sparrow D, O'Connor GT, Rosner B, Weiss ST (With the technical assistance of Demolles D). Predictors of longitudinal change in methacholine airway responsiveness among middle-aged and older men: The normative aging study. Am J Respir Crit Care Med 1994; 149:376-81.
42. de Jong JW, Postma DS, van der Mark ThW, Koëter GH. Effects of nedocromil sodium in the treatment of non-allergic subjects with chronic obstructive pulmonary disease. Thorax 1994; 49:1022-24.
43. Auffarth B, Postma DS, de Monchy JGR et al. Effects of inhaled budesonide on spirometric values, reversiblility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease. Thorax 1991; 46:372-7.
44. Watson A, Lim TK, Joyce H, Pride NB. Failure of inhaled corticosteroids to modify bronchoconstrictor or bronchodilator responsiveness in middle-aged smokers with mild airflow obstruction. Chest 1992; 101:350-5.
45. Engel T, Heinig JH, Madsen O, Hansen M, Weeke ER. A trial of inhaled budesonide on airway responsiveness in smokers with chronic bronchitis. Eur Respir J 1989; 2:935-9.
46. Renkema TEJ, Schouten JP, Koëter GH, Postma DS. Effects of long-term treatment with corticosteroids in chronic obstructive pulmonary disease. Chest 1996; 109:1156-62.
47. Dompeling E, van Schayck CP, Molema J et al. Inhaled beclomethasone improves the course of asthma and COPD. Eur Respir J 1992; 945-52.
48. Callahan Ch. M, Dittus RS, Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. Ann of Int Med 1991; 114:216-23.
49. Pauwels RA, Löfdahl CG, Pride NB et al. European respiratory society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design. Eur Respir J 1992; 5:1254-61.